YoVDO

Innovations in First Line Therapy for DLBCL - 7 February 2024

Offered By: Stanford Department of Medicine via YouTube

Tags

Oncology Courses Hematology Courses Clinical Trials Courses Cancer Treatment Courses Cancer Research Courses Targeted Therapy Courses Immunotherapy Courses Lymphomas Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore cutting-edge advancements in first-line therapy for Diffuse Large B-Cell Lymphoma (DLBCL) in this informative Grand Rounds presentation. Led by Dr. Christopher Flowers, Head of the Division of Cancer Medicine and Chair of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, the 54-minute talk delves into the latest research and treatment strategies. Gain valuable insights into innovative approaches that are shaping the future of DLBCL management and improving patient outcomes. This presentation, hosted by the Stanford Department of Medicine, offers a unique opportunity to stay abreast of the evolving landscape in lymphoma treatment.

Syllabus

Innovations in First Line Therapy for DLBCL | DoM Grand Rounds | 7 February 2024


Taught by

Stanford Department of Medicine

Related Courses

Cancer in the 21st Century: The Genomic Revolution
University of Glasgow via FutureLearn
Inside Cancer: How Genes Influence Cancer Development
University of Bath via FutureLearn
Cancer Immunotherapy: a Step Change in Cancer Treatment
University of Birmingham via FutureLearn
Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn
Discovering Science: Medicinal Chemistry
University of Leeds via FutureLearn